Skip to main content

Closed

RNXT: RenovoRx, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

34thpctl

Volume

0.94×avg

Market Cap

35.67MUSD

P/E Ratio

-2.9TTM

Div Yield

-ann

RenovoRx, Inc.

RNXTNASDAQ Capital Market·USD·Closed

RenovoRx, Inc.

RNXTNASDAQ·USD·Closed

$0.96

+1.82%

$0.96

+$0.02 (1.82%)

52W Range

34thpctl

Volume

0.94×avg

Mkt Cap

35.67MUSD

P/E

-2.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings